Globally, harmful alcohol use continues to be a major modifiable contributor to the burden of disease.
Patterns of alcohol and drug use
This research project seeks to examine the patterns and costs of Pharmaceutical Benefits Scheme-subsidised opioid use, including extra-medical use, in the Australian population.
We will identify a population cohort of people who use opioids, examine hospitalisations and emergency department visits in this group and determine the impacts of opioid substitution therapy on hospitalisation and emergency department visits.
This project aims to describe patterns of AAS and PIEDs use; where people are sourcing them from and why; users' experience of harms; and users' utilisation of health services.
This study will use a highly innovative approach to pool data from four large and long-running Australasian cohort studies to better understand the developmental precursors and psychosocial consequences of teen drinking behaviours.
This study was the first of its kind to use integrative data analyses – a highly innovative approach – to pool data from four large and long-running Australasian cohort studies to better understand the link between cannabis use and later-life outcomes.
Childhood physical abuse is common amongst drug users. This body of work examines the extent and nature of childhood physical abuse amongst regular drug users, and its relationship to later drug use and violence.
The intravenous injection of drugs intended for oral use can cause pulmonary granulamatosis. This project aims to determine the number of cases of sudden or unnatural deaths in which pulmonary granulamatosis was diagnosed, and the medical consequences of pulmonary granulamatosis.
There has been a great deal of clinical concern regarding alprazolam (Xanax) abuse, so much so that the Therapeutic Goods Administration reclassified the drug effective 1 February 2014 from Schedule 4 (prescription only medicine) to Schedule 8 (controlled drug).